Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 18, Issue 2, Pages 244-251
Publisher
Oxford University Press (OUP)
Online
2015-08-20
DOI
10.1093/neuonc/nov162
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-Analysis Study on the Role of Bone-Derived Neurotrophic Factor Val66Met Polymorphism in Parkinson's Disease
- (2015) Stefania Mariani et al. REJUVENATION RESEARCH
- Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis
- (2014) Daniel Hind et al. BMC Psychiatry
- Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patients
- (2014) Yin Ting Cheung et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- BDNF Polymorphisms Are Linked to Poorer Working Memory Performance, Reduced Cerebellar and Hippocampal Volumes and Differences in Prefrontal Cortex in a Swedish Elderly Population
- (2014) Samantha J. Brooks et al. PLoS One
- Effect of BDNF Val66Met polymorphism on regional white matter hyperintensities and cognitive function in elderly males without dementia
- (2013) Chu-Chung Huang et al. PSYCHONEUROENDOCRINOLOGY
- Psychometric Properties and Measurement Equivalence of the English and Chinese Versions of the Functional Assessment of Cancer Therapy-Cognitive in Asian Patients With Breast Cancer
- (2013) Yin Ting Cheung et al. VALUE IN HEALTH
- Cognitive Changes Associated with Cancer and Cancer Therapy: Patient Assessment and Education
- (2013) Catherine E. Jansen Seminars in Oncology Nursing
- Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review
- (2012) Amanda D. Hutchinson et al. CANCER TREATMENT REVIEWS
- Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
- (2012) Tim A. Ahles et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy
- (2012) Heather S.L. Jim et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
- (2011) Jeffrey S Wefel et al. LANCET ONCOLOGY
- Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function
- (2010) Antonio Lucio Teixeira et al. Biomarkers in Medicine
- Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors
- (2010) Brent J. Small et al. CANCER
- Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults
- (2010) Tanja Richter-Schmidinger et al. JOURNAL OF NEURAL TRANSMISSION
- STrengthening the REporting of Genetic Association studies (STREGA) - an extension of the STROBE statement
- (2009) Julian Little et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Evaluating the Dimensionality of Perceived Cognitive Function
- (2009) Jin-Shei Lai et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Subjective cognitive dysfunction in breast cancer patients: a systematic review
- (2009) Marleen J.J. Pullens et al. PSYCHO-ONCOLOGY
- Genetic Association Studies
- (2008) Kathryn L. Lunetta CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now